| Dr Thomas Jose Eluvathingal, MD,MB;BS | |
|
3848 Fau Blvd Ste 305, Boca Raton, FL 33431-6437 | |
| (561) 455-3627 | |
| (305) 243-4613 |
| Full Name | Dr Thomas Jose Eluvathingal |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 26 Years |
| Location | 3848 Fau Blvd Ste 305, Boca Raton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114188547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | ME152194 (Florida) | Secondary |
| 2085N0904X | Radiology - Nuclear Radiology | ME152194 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jackson Health System | Miami, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Miami | 3274795109 | 1781 |
News Archive
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.
Altosoft, an innovator in the field of healthcare informatics and business intelligence, today announced that Health Network Laboratories, has chosen to implement Altosoft's Insight system at its anatomic and clinical pathology labs in Pennsylvania and New Jersey. With 46 locations throughout the two states, HNL, an affiliate of the Lehigh Valley Health Network, processes nearly five and a half million clinical and anatomic pathology tests each year.
The coronavirus disease (COVID-19) is potentially fatal for vulnerable populations like seniors who over 60 years old, and those with underlying medical conditions, like heart disease, diabetes, and lung disease. Reports show that patients are suffering from heart impairment caused by COVID-19. A new study sheds light on the effect of the novel coronavirus on the heart, causing cardiovascular problems, even in those without underlying heart conditions.
› Verified 2 days ago
| Entity Name | University Of Miami |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.
Altosoft, an innovator in the field of healthcare informatics and business intelligence, today announced that Health Network Laboratories, has chosen to implement Altosoft's Insight system at its anatomic and clinical pathology labs in Pennsylvania and New Jersey. With 46 locations throughout the two states, HNL, an affiliate of the Lehigh Valley Health Network, processes nearly five and a half million clinical and anatomic pathology tests each year.
The coronavirus disease (COVID-19) is potentially fatal for vulnerable populations like seniors who over 60 years old, and those with underlying medical conditions, like heart disease, diabetes, and lung disease. Reports show that patients are suffering from heart impairment caused by COVID-19. A new study sheds light on the effect of the novel coronavirus on the heart, causing cardiovascular problems, even in those without underlying heart conditions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Jose Eluvathingal, MD,MB;BS 3848 Fau Blvd Ste 305, Boca Raton, FL 33431-6437 Ph: (561) 455-3627 | Dr Thomas Jose Eluvathingal, MD,MB;BS 3848 Fau Blvd Ste 305, Boca Raton, FL 33431-6437 Ph: (561) 455-3627 |
News Archive
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.
Altosoft, an innovator in the field of healthcare informatics and business intelligence, today announced that Health Network Laboratories, has chosen to implement Altosoft's Insight system at its anatomic and clinical pathology labs in Pennsylvania and New Jersey. With 46 locations throughout the two states, HNL, an affiliate of the Lehigh Valley Health Network, processes nearly five and a half million clinical and anatomic pathology tests each year.
The coronavirus disease (COVID-19) is potentially fatal for vulnerable populations like seniors who over 60 years old, and those with underlying medical conditions, like heart disease, diabetes, and lung disease. Reports show that patients are suffering from heart impairment caused by COVID-19. A new study sheds light on the effect of the novel coronavirus on the heart, causing cardiovascular problems, even in those without underlying heart conditions.
› Verified 2 days ago
Dr. Anastasia Frances Barron, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 951 Nw 13th St Ste 1d, Boca Raton, FL 33486 Phone: 312-724-8477 | |
Dr. Ira J Braunschweig, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 951 Nw 13th St, Suite 1c, Boca Raton, FL 33486 Phone: 561-447-9341 Fax: 561-447-9352 | |
Dr. Craig Kolodziej, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 951 Nw 13th St, Suite 1c, Boca Radiology Group, Boca Raton, FL 33486 Phone: 561-447-9341 | |
Surya Vaidyanathan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 800 Meadows Rd, Suite 1c, Boca Raton, FL 33486 Phone: 561-447-9341 | |
Dr. Sabrina Yvette Saida, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-447-9341 Fax: 561-447-9352 | |
Dr. Edward Victor Grayson, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3435 Windsor Pl, Boca Raton, FL 33496 Phone: 561-926-3230 |